What is Enter?
Enter is dedicated to improving the lives of doctors and patients by revolutionizing Revenue Cycle Management (RCM). The company's mission is to empower physicians to concentrate on patient care rather than administrative complexities. By developing a superior RCM platform and service, Enter aims to restore the focus on the core practice of medicine. The company's innovative approach addresses critical pain points in healthcare administration, seeking to make the practice of medicine more sustainable and rewarding for providers.
How much funding has Enter raised?
Enter has raised a total of $6M across 3 funding rounds:
Debt
$150K
Debt
$147K
Angel/Seed
$5.7M
Debt (2020): $150K with participation from PPP
Debt (2021): $147K led by PPP
Angel/Seed (2022): $5.7M supported by Menlo Ventures, Savantus Ventures, Quiet Capital, SpringRock Ventures, and 500.com
Key Investors in Enter
Menlo Ventures
Menlo Ventures is a venture capital firm specializing in early and growth-stage technology companies across various sectors, including enterprise software and fintech. They actively partner with founders through multiple stages of company scaling.
Savantus Ventures
Savantus Ventures operates within the Venture Capital & Private Equity industry, based in Nyack, New York, and focuses on investing in technology companies.
SpringRock Ventures
SpringRock Ventures is an investment firm concentrating on the intersection of healthcare and information technology, supporting high-growth companies in sectors like SAAS and genomics with funding and strategic guidance.
What's next for Enter?
With the recent influx of major strategic investment, Enter is poised for accelerated growth and innovation. The company's focus on the healthcare RCM sector, a critical area for operational efficiency and financial health, positions it for significant impact. Future developments are likely to include enhancements to its platform, expansion of its service offerings, and potentially broader market penetration. The strategic backing suggests a validation of Enter's business model and its potential to disrupt the traditional RCM landscape, enabling more healthcare providers to optimize their operations and enhance patient care.
See full Enter company page
